Clinically, TRIM44 expression was significantly downregulated in ccRCC tissues compared with adjacent normal tissues, and its reduced expression correlated with advanced tumor stage and poor patient prognosis. This evidence concerns the gene TRIM44 and nonpapillary renal cell carcinoma.